News
HLN
9.82
-0.30%
-0.03
Haleon price target raised to 420 GBp from 400 GBp at Morgan Stanley
TipRanks · 2d ago
Morgan Stanley Remains a Buy on Haleon PLC (HLN)
TipRanks · 2d ago
Weekly Report: what happened at HLN last week (1208-1212)?
Weekly Report · 2d ago
Haleon Recognized by Fast Company as a 2025 Brands That Matter Honoree
Barchart · 5d ago
Tuesday's ETF with Unusual Volume: QLTI
NASDAQ · 12/09 19:04
Weekly Report: what happened at HLN last week (1201-1205)?
Weekly Report · 12/08 09:57
Haleon: Fairly Priced Given Limited Growth Drivers
Seeking Alpha · 12/08 07:54
What Does the Market Think About Haleon PLC?
Benzinga · 12/05 19:00
Weekly Report: what happened at HLN last week (1124-1128)?
Weekly Report · 12/01 09:54
JP Morgan Cazenove Reiterates Haleon plc - Depositary Receipt (HLN) Underweight Recommendation
NASDAQ · 11/28 04:03
Haleon PLC (HLN) Receives a Sell from J.P. Morgan
TipRanks · 11/26 16:05
First Eagle Overseas Equity ETF Q3 2025 Portfolio Update
Seeking Alpha · 11/26 07:40
EUROPE RESEARCH ROUNDUP- Carlsberg, Genus, Renk Group
Reuters · 11/26 07:16
Altibbi Teams Up With Sensodyne Maker To Boost Oral Health Access In Saudi Arabia
Benzinga · 11/24 11:20
Weekly Report: what happened at HLN last week (1117-1121)?
Weekly Report · 11/24 09:58
Weekly Report: what happened at HLN last week (1110-1114)?
Weekly Report · 11/17 09:58
Bullish Two Hundred Day Moving Average Cross - HLN
NASDAQ · 11/13 22:15
Haleon PLC (HLN) Gets a Buy from Kepler Capital
TipRanks · 11/13 01:47
Pre-Market Most Active for Nov 10, 2025 : IFRX, GREE, IPHA, TSLL, SQQQ, NVDA, PFE, BBAI, OSCR, IONQ, HLN, THS
NASDAQ · 11/10 13:28
Weekly Report: what happened at HLN last week (1103-1107)?
Weekly Report · 11/10 09:56
More
Webull provides a variety of real-time HLN stock news. You can receive the latest news about Haleon through multiple platforms. This information may help you make smarter investment decisions.
About HLN
Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.